QA: Nuvectis Pharma Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001875558_2023_Nuvectis_Pharma_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001875558', 'EntityCommonStockSharesOutstanding': 14642483, 'Assets': 20405000, 'AssetsCurrent': 20405000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 6186000, 'LiabilitiesAndStockholdersEquity': 20405000, 'LiabilitiesCurrent': 6186000, 'LiabilitiesNoncurrent': 0, 'NetIncome': -19085000, 'PropertyPlantAndEquipmentNet': 0, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 149000, 'SellingGeneralAndAdministrativeExpense': 0, 'TemporaryEquity': 0, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 14219000, 'remainder_NetIncome': -19234000, 'remainder_Revenues': 149000, 'obs_EconomicCapitalRatio': nan}}
warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001875558', 'EntityCommonStockSharesOutstanding': 17326594, 'Assets': 19185000, 'AssetsCurrent': 19185000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 6984000, 'LiabilitiesAndStockholdersEquity': 19185000, 'LiabilitiesCurrent': 6984000, 'LiabilitiesNoncurrent': 0, 'NetIncome': -22260000, 'PropertyPlantAndEquipmentNet': 0, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 637000, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 0, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 12201000, 'remainder_NetIncome': -22897000, 'remainder_Revenues': 637000, 'obs_EconomicCapitalRatio': nan}}

Edgar->Model Mapping